BDBM172384 US9090618, H30b(ii)::US9598411, Ref. No. H30b(ii)

SMILES OC(=O)CN1CCC[C@@H]1c1nc2ccccc2n1[C@@H]1C[C@@H]2CCC[C@H](C1)N2[C@H]1C[C@@H]2C[C@H](C1)CCCC2

InChI Key InChIKey=CLHWZIKMCHBNFA-UHFFFAOYSA-N

Data  8 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 172384   

TargetOpioid growth factor receptor-like protein 1(Human)
Purdue Pharma

US Patent
LigandPNGBDBM172384(US9090618, H30b(ii) | US9598411, Ref. No. H30b(ii))
Affinity DataKi:  9nM ΔG°:  -11.0kcal/molepH: 7.4 T: 2°CAssay Description:Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 ug membrane protein in a fin...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetNociceptin receptor(Human)
Purdue Pharma

US Patent
LigandPNGBDBM172384(US9090618, H30b(ii) | US9598411, Ref. No. H30b(ii))
Affinity DataKi:  9nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 &#...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKappa-type opioid receptor(Human)
Purdue Pharma

US Patent
LigandPNGBDBM172384(US9090618, H30b(ii) | US9598411, Ref. No. H30b(ii))
Affinity DataKi:  65.2nMpH: 7.4Assay Description:Radioligand dose displacement assays used 0.4-0.8 nM [3H]-U69,593 (NEN; 40 Ci/mmole) with 10-20 μg membrane protein (recombinant kappa opioid re...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKappa-type opioid receptor(Human)
Purdue Pharma

US Patent
LigandPNGBDBM172384(US9090618, H30b(ii) | US9598411, Ref. No. H30b(ii))
Affinity DataKi:  65.2nMAssay Description:μ-Opioid Receptor Binding Assay Procedures: Radioligand binding assays were conducted using freshly thawed membranes expressing human μ-rec...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetMu-type opioid receptor(Human)
Purdue Pharma

US Patent
LigandPNGBDBM172384(US9090618, H30b(ii) | US9598411, Ref. No. H30b(ii))
Affinity DataKi:  1.11E+3nM ΔG°:  -8.12kcal/molepH: 7.4 T: 2°CAssay Description:Radioligand binding assays were conducted using freshly thawed membranes expressing human mu-receptors (Perkin Elmer, Shelton, Conn.). Radioligand do...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetMu-type opioid receptor(Human)
Purdue Pharma

US Patent
LigandPNGBDBM172384(US9090618, H30b(ii) | US9598411, Ref. No. H30b(ii))
Affinity DataKi:  1.11E+3nMAssay Description:κ-Opioid Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human kappa opioid receptor (kappa) (cloned ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetDelta-type opioid receptor(Human)
Purdue Pharma

US Patent
LigandPNGBDBM172384(US9090618, H30b(ii) | US9598411, Ref. No. H30b(ii))
Affinity DataKi:  5.28E+3nMpH: 7.4Assay Description:Radioligand dose-displacement assays used 0.2 nM [3H]-Naltrindole (NEN; 33.0 Ci/mmole) with 10-20 μg membrane protein (recombinant delta opioid ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetDelta-type opioid receptor(Human)
Purdue Pharma

US Patent
LigandPNGBDBM172384(US9090618, H30b(ii) | US9598411, Ref. No. H30b(ii))
Affinity DataKi:  5.28E+3nMAssay Description:ORL-1 Receptor Binding Assay Procedures: Membranes from recombinant HEK-293 cells expressing the human opioid receptor-like receptor (ORL-1) (Recepto...More data for this Ligand-Target Pair
In DepthDetails
US Patent